Promotion of immunity of mice to Pasteurella multocida and hog cholera vaccine by pig interleukin-6 gene and CpG motifs

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 32, Issue 3, 2009, Pages 191-205

  Zhao, Zhong Zhong ^a   Zhang, Hua Bing ^a   Chen, Qian ^a   Su, Dan ^a   Xie, Zhao ^a   Wang, Ying Yu ^a   Yang, Yi ^a   Wang, Ze Zhou ^a   Li, Jiang Ling ^a   Wu, Kai Yuan ^a   Wang, Hong Ning ^a   Meng, Min Jie ^b   Gao, Rong ^a  

^a SICHUAN UNIVERSITY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

CpG motifs; Hog cholera; Immunity; Mouse; Pasteurella multocida; Pig IL 6 gene

Indexed keywords

BACTERIAL VACCINE; BACTERIUM ANTIBODY; CHITOSAN; CPG OLIGODEOXYNUCLEOTIDE; HOG CHOLERA VACCINE; IMMUNOGLOBULIN; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PASTEURELLA MULTOCIDA VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GRAM NEGATIVE INFECTION; INFECTION RESISTANCE; LYMPHOCYTE COUNT; MONOCYTE; MOUSE; NONHUMAN; PASTEURELLA MULTOCIDA; RECOMBINANT PLASMID; SWINE; SWINE DISEASE; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BACTERIAL VACCINES; CHITOSAN; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; FEMALE; IMMUNOGLOBULINS; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; NANOPARTICLES; OLIGODEOXYRIBONUCLEOTIDES; PASTEURELLA INFECTIONS; PASTEURELLA MULTOCIDA; PLASMIDS; SWINE; VACCINES, DNA; VIRAL VACCINES;

ANIMALIA; MUS; PASTEURELLA MULTOCIDA; SUIDAE;

EID: 61749083242     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cimid.2007.10.001     Document Type: Article

References (19)

1. Cox J.C., and Coulter A.R. Adjutants-a classification and review of their modes of action. Vaccine 15 (1998) 248-256
2. Leclerc C., and Ronco J. New approaches in vaccine development. Immunol Today 9 (1998) 300-302
3. Kim J.J., Yang J.S., Montaner L., Lee D.J., Chalian A.A., and Weiner D.B. Co-immunization with IFN-gamma or IL-2, but not IL-13 and IL-4 cDNA can enhance Th1-type DNA vaccine-induced immune responses in vivo. J Interferon Cytokine Res (2000) 20311-20319
4. Callard R., George A.J.T., and Stark J. Cytokines chaos and complexity. Immunity 11 (1999) 507-513
5. Wu M., Gao R., Meng M.J., Li J.L., Tan M.S., Shen Y., et al. Regulating effect of pig interleukin-6 gene and CpG motifs on immune responses to pig trivalent vaccines in mice. Res Vet Sci 77 (2004) 49-57
6. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-549
7. Marshall J.D., Fearon K., Abbate C., Subramanian S., Yee P., Gregorio J., et al. Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions. J Leukoc Biol 73 (2003) 781-792
8. Marschner A., Rothenfusser S., Hornung V., Prell D., Krug A., Kerkmann M., et al. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells. Eur J Immunol 35 (2005) 2347-2357
9. Wu K.Y., Wu M., Fu M.L., Li H., Yang Y., Zhang H., et al. A novel chitosan CpG nanoparticle regulates cellular and humoral immunity of mice. Biomed Environ Sci 19 (2006) 87-95
10. Murphy J.C., Wibbenmeyer J.A., Fox G.E., and Willson R.C. Purification of plasmid DNA using selective precipitation by compaction agents. Nat Biotechnol 17 (1999) 822-823
11. Yang Y., Chen J.L., Li H., Wang Y.Y., Xie Z., Wu M., et al. Pig interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine. Comp Immunol Microbiol Infect Dis 30 1 (2007) 19-32 10.1016/j.cimid.09.006
12. Wang Y., and Krieg A.M. Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation. Int Immunol 15 (2003) 223-231
13. Sugai T., Mori M., Nakazawa M., Ichino M., Naruto T., Kobayashi N., et al. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine. Vaccine 23 (2005) 5450-5456
14. Krieg A.M. Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides. Curr Oncol Rep 6 (2004) 88-95
15. Weeratna R.D., Mccluskie M.J., Xu Y., and Davis H.L. CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine 18 (2000) 1755-1762
16. Abraham E.J., and Minton J.E. Cytokines in the hypothesis: a comparative look at interleukin-6 in the pig anterior pituitary gland. Comp Biochem Physiol 118B (1997) 203-207
17. Kojima Y., Xin K.Q., Ooki T., Hamajima K., Oikawa T., Shinoda K., et al. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine. Vaccine 20 (2002) 2857-2865
18. Ramsay A.J., Husband A.J., and Ramshaw L.A. The role of interleukin-6 in mucosal antibody responses in vitro. Science 264 (1994) 561-563
19. Mao H.Q., Roy K., Troung-Le V.L., Janes K.A., Lin K.Y., Wang Y., et al. Chitsan-DNA nanoparticles as gene carrier, synthesis, characterization and transfection efficiency. J Control Release 70 (2000) 39-421